NorthStar Medical Radioisotopes
We're hiring — explore open roles below and apply in a few clicks.
Location
Headquarters: Madison, Wisconsin, United States, North America
Region: Wisconsin
Country: US
Continent: North America
About
NorthStar Medical Radioisotopes is a radiopharmaceutical contract development and manufacturing organization focused on producing radiopharmaceuticals for cancer and other serious diseases. The company develops non-reactor production processes for actinium-225 and copper-67 on a single campus in Beloit, Wisconsin, enabling global access to novel radiopharmaceutical therapies. It positions itself as an emerging leader in nuclear medicine technology, supplying CDMO/CMO services and advancing radiopharmaceutical science through manufacturing and development capabilities.
NorthStar Medical Radioisotopes is a radiopharmaceutical contract development and manufacturing organization that produces radioisotopes for diagnostic and therapeutic applications. The company specializes in non-reactor production processes for isotopes such as actinium-225 and copper-67, serving biopharmaceutical clients with CDMO and CMO services. Its facilities support the development of advan
Northstar Medical Technologies LLC
2006
for_profit
active
Industries
Primary Industry: Business Services
Categories
Funding & Financials
Grant
111100000
1m-10m
private
Investors
Founders
George Messina
Glenn Isensee
Leadership
Technology Stack
Products
Copper-67 (Cu-67): Copper-67 is a radioisotope produced for use in clinical trials targeting cancer treatment.
Actinium-225 (Ac-225): Actinium-225 is a therapeutic radioisotope produced for targeted radiopharmaceutical cancer therapies.
Molybdenum-99 (Mo-99): Molybdenum-99 is a radioisotope produced domestically without uranium, used to generate technetium-99m for diagnostic imaging.
RadioGenix® System: An automated technetium-99m generator system that processes non-uranium based molybdenum-99 to produce technetium-99m for diagnostic use.
Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO/CMO) Services: Customized development and manufacturing services for radiopharmaceuticals to support biopharmaceutical companies’ clinical and commercial programs.
